 |
N-[(1R)-1-phenylethyl]-6-{1H-pyrazolo[3,4-d]pyrimidin-4-yl}quinazolin-2-amine |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| EU Market Approval | EU |
| EU Designation Date | 2017-04-20 00:00:00 |
| Sponsor | Sentinel Oncology Limited |
| |
N-[(1R)-1-phenylethyl]-6-{1H-pyrazolo[3,4-d]pyrimidin-4-yl}quinazolin-2-amine |
|---|---|
| Trade Name | |
| Orphan Indication | Fragile X syndrome |
| EU Market Approval | EU |
| EU Designation Date | 2017-04-20 00:00:00 |
| Sponsor | Sentinel Oncology Limited |